Based on 4 analysts offering 12 month price targets for Cardlytics Inc
Min Forecast
$3.50-9.79%
Avg Forecast
$4.38+12.76%
Max Forecast
$5.00+28.87%
Should I buy or sell CDLX stock?
Based on 4 analysts offering ratings for Cardlytics Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
3 analysts 75%
Sell
1 analysts 25%
Strong Sell
0 analysts 0%
Although CDLX's forecast from analysts indicates a "Hold", our proven Zen Rating quant model rates CDLX as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More
Be the first to know when Wall Street analysts revise their CDLX stock forecasts and price targets.
CDLX stock forecasts by analyst
Analyst / Firm
Rating
Action
Price Target
Upside/Downside
Date
Analyst Color
locked
locked
$00.00
+00.00%
2024-10-11
locked
locked
$00.00
+00.00%
2024-08-16
locked
locked
$00.00
+00.00%
2024-08-15
locked
locked
$00.00
+00.00%
2024-08-08
1 of 1
Forecast return on equity
Is CDLX forecast to generate an efficient return?
Company
N/A
Industry
43.65%
Market
230.57%
Forecast return on assets
Is CDLX forecast to generate an efficient return on assets?
Company
N/A
Industry
8.44%
CDLX earnings per share forecast
What is CDLX's earnings per share in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$1.70
CDLX revenue forecast
What is CDLX's revenue in the next 1 years based on estimates from 1 analyst?
Is Cardlytics Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 4 Wall Street analysts covering (NASDAQ: CDLX) stock is to Hold CDLX stock.
Out of 4 analysts, 0 (0%) are recommending CDLX as a Strong Buy, 0 (0%) are recommending CDLX as a Buy, 3 (75%) are recommending CDLX as a Hold, 1 (25%) are recommending CDLX as a Sell, and 0 (0%) are recommending CDLX as a Strong Sell.
What is CDLX's earnings growth forecast for 2025-2025?
(NASDAQ: CDLX) Cardlytics's forecast annual earnings growth rate of N/A is not forecast to beat the US Advertising Agencies industry's average forecast earnings growth rate of 211.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 59.2%.
Cardlytics's earnings in 2025 is -$274,550,000.
In 2025, CDLX is forecast to generate -$86,398,153 in earnings, with the lowest earnings forecast at -$86,398,153 and the highest earnings forecast at -$86,398,153.
What is CDLX's revenue growth forecast for 2025-2025?
(NASDAQ: CDLX) Cardlytics's forecast annual revenue growth rate of -3.4% is forecast to beat the US Advertising Agencies industry's average forecast revenue growth rate of -4.78%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 19.19%.
Cardlytics's revenue in 2025 is $293,468,000.
In 2025, CDLX is forecast to generate $14,408,162,591 in revenue, with the lowest revenue forecast at $14,408,162,591 and the highest revenue forecast at $14,408,162,591.
What is CDLX's forecast return on assets (ROA) for 2025-2026?
(NASDAQ: CDLX) forecast ROA is N/A, which is lower than the forecast US Advertising Agencies industry average of 8.44%.
What is CDLX's Price Target?
According to 4 Wall Street analysts that have issued a 1 year CDLX price target, the average CDLX price target is $4.38, with the highest CDLX stock price forecast at $5.00 and the lowest CDLX stock price forecast at $3.50.
On average, Wall Street analysts predict that Cardlytics's share price could reach $4.38 by Oct 11, 2025. The average Cardlytics stock price prediction forecasts a potential upside of 12.76% from the current CDLX share price of $3.88.
What is CDLX's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: CDLX) Cardlytics's current Earnings Per Share (EPS) is -$6.29. In 2025, CDLX's EPS is forecast to hit -$1.70 (min: -$1.70, max: -$1.70).
What is CDLX's forecast return on equity (ROE) for 2025-2026?
(NASDAQ: CDLX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.